O&G Vivas · Reproductive endocrinology & infertility
Congenital uterine anomalies — structured oral station (12 minutes)
FRANZCOG oral-format station on congenital uterine anomalies: candidate navigates the three classification systems, the prevalence variation and its mechanism, the ESHRE/ESGE diagnostic tier, the septate-versus-bicornuate distinction, hysteroscopic metroplasty, and the limits of the observational evidence. Scored against the eight published RANZCOG oral domains.
On this page & tools
Target exams
Station format
4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply to every station: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport with patient, support person or colleague; respect; communication skills. You are being marked on how you behave, not only what you know.[2]
Reveal the examiner script and model responses
Opening prompt — "Tell me how you classify this woman's anomaly and how you would confirm it."
Model response — say it in this order:[2][4]
- "Three classification systems exist: the 1988 American Fertility Society classification, the 2013 ESHRE/ESGE CONUTA system — which is anatomy-based with classes U0 to U6, where septate is U2 — and the 2021 ASRM Müllerian Anomalies Classification, which is built on the 1988 system but expanded to include the vagina and cervix."[1][2][3]
- "Before I label this a septate uterus I need to confirm it under a defined criterion and, critically, assess the external fundal contour. The ESHRE/ESGE Thessaloniki consensus recommends 3D transvaginal ultrasound as first-line for a symptomatic, high-risk woman — it renders the coronal plane and shows both the cavity and the external contour in one view."[4]
- "If the external contour is normal with an internal indentation, it is a septate uterus. If there is an external fundal cleft, it is a bicornuate uterus — and that distinction changes everything."[4]
Probe 1 — "The report says the indentation is about 1 cm. Is that a septate uterus?"
- "It depends entirely on which criteria I apply. Under the CUME definition — internal indentation at least 1 cm with external indentation under 1 cm — yes. Under the ASRM criterion it needs to be at least 1.5 cm with an angle under 90 degrees. Under ESHRE/ESGE it must exceed 50% of the uterine wall thickness."[6]
- "This discordance is well described: in the Ludwin CUME study only 2.7% of women met all three definitions, and the ESHRE/ESGE criteria diagnosed septate about six times more often than ASRM. I would want the 3D volumes reviewed by someone experienced before committing to a diagnosis and certainly before surgery."[6]
Probe 2 — "She has had three miscarriages. How does that change your prevalence thinking?"
- "The prevalence of uterine anomalies rises with reproductive risk. In the Chan meta-analysis, by optimal tests it is about 5.5% in the unselected population, 8% in infertile women, 13.3% in those with miscarriage, and 24.5% in women with both miscarriage and infertility."[5]
- "Septate uterus is the commonest anomaly in high-risk groups like hers, which is why it is the anomaly we most often operate on. Arcuate uterus is the commonest in the unselected population but behaves near-normally."[5]
Probe 3 — "She asks whether she should have the septum resected. What do you tell her about the evidence?"
- "I would tell her that observational studies suggest benefit — the Wu meta-analysis found a higher term-delivery rate after resection, with an odds ratio of about 2.3 — but that the evidence is mainly from before-and-after studies, which inherently favour the intervention."[8]
- "The 2025 Cochrane review is explicit about this flaw, and the definitive randomised trial, TRUST, was still accruing at protocol publication. So the benefit is plausible but not yet randomised-trial-proven, and I would counsel her honestly on that before she decides."[7]
- "For a woman with three losses and a confirmed septate uterus under agreed criteria, I would offer hysteroscopic metroplasty, because recurrent loss is the clearest indication — but I would frame it as a reasonable offer on observational evidence, not a guaranteed fix."[2][7]
Probe 4 — "She is frightened about the surgery itself. What are the risks, and how will you follow her up?"
Rapport and respect are scored domains — demonstrate the counselling out loud:[2]
- "I would move to her eye level, use her name, and explain plainly: hysteroscopic metroplasty is a day-case keyhole procedure through the cervix, with no abdominal incision. The main risks are uterine perforation, fluid overload, cervical trauma, and postoperative intrauterine adhesions — which occur in roughly a quarter of women after septum resection."[7]
- "I would plan adhesion prevention and a second-look hysteroscopy where practised. And I would tell her that even after resection, she remains at higher risk of preterm birth and placental complications, so her pregnancies will be consultant-led with a surveillance plan."[7][8]
- "I would also image her renal tract, because Müllerian and renal development share embryological proximity, and offer her a follow-up appointment to revisit the decision and answer her questions."[4]
Probe 5 — "How would your answer change if the external contour showed a cleft?"
- "Then this is a bicornuate uterus, not a septate uterus, and hysteroscopic resection is the wrong operation — it would resect functional myometrium and risk perforation."[2]
- "A bicornuate uterus with significant reproductive morbidity, if surgery is warranted, needs an abdominal unification metroplasty — the Strassman procedure — now usually laparoscopic. The defence is always the same: see the external contour before you cut."[2]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship atlas.
References8Show ledgerHide ledger
- [1]The American Fertility Society The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions Fertility and sterility, 1988.PMID 3371491
- [2]Grimbizis GF, Gordts S, Di Spiezio Sardo A, Brucker S, De Angelis C, Gergolet M, Li TC, Tanos V, Brölmann H, Gianaroli L, Campo R The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies Human reproduction (Oxford, England), 2013.PMID 23771171
- [3]Pfeifer SM, Attaran M, Goldstein J, Lindheim SR, Petrozza JC, Rackow BW, Siegelman E, Troiano R, Winter T, Zuckerman A, Ramaiah SD ASRM müllerian anomalies classification 2021 Fertility and sterility, 2021.PMID 34756327
- [4]Grimbizis GF, Di Spiezio Sardo A, Saravelos SH, Gordts S, Exacoustos C, Van Schoubroeck D, Bermejo C, Amso NN, Nargund G, Timmermann D, Athanasiadis A, Brucker S, De Angelis C, Gergolet M, Li TC, Tanos V, Tarlatzis B, Farquharson R, Gianaroli L, Campo R The Thessaloniki ESHRE/ESGE consensus on diagnosis of female genital anomalies Gynecological surgery, 2016.PMID 26918000
- [5]Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N, Coomarasamy A The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review Human reproduction update, 2011.PMID 21705770
- [6]Ludwin A, Ludwin I, Coelho Neto MA, Nastri CO, Bhagavath B, Lindheim SR, Martins WP Septate uterus according to ESHRE/ESGE, ASRM and CUME definitions: association with infertility and miscarriage, cost and warnings for women and healthcare systems Ultrasound in obstetrics & gynecology, 2019.PMID 30977223
- [7]Joosse MI, Kostova EB, Rikken JF, Mol BWJ, Goddijn M, van Wely M Septum resection for women of reproductive age with a septate uterus The Cochrane database of systematic reviews, 2025.PMID 41268817
- [8]Wu X, Zhang M, Sun P, Jiang JJ, Yan L Pregnancy and Adverse Obstetric Outcomes After Hysteroscopic Resection: A Systematic Review and Meta-Analysis Frontiers in surgery, 2022.PMID 35832500